UBS Group’s Aehr Test Systems AEHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.15M | Buy |
246,763
+3,634
| +1% | +$116K | ﹤0.01% | 3461 |
|
|
2025
Q4 | $4.91M | Buy |
243,129
+87,014
| +56% | +$2.1M | ﹤0.01% | 4050 |
|
|
2025
Q3 | $4.7M | Buy |
156,115
+14,872
| +11% | +$322K | ﹤0.01% | 4105 |
|
|
2025
Q2 | $1.83M | Sell |
141,243
-68,696
| -33% | -$654K | ﹤0.01% | 4918 |
|
|
2025
Q1 | $1.53M | Buy |
209,939
+4,403
| +2% | +$48.7K | ﹤0.01% | 4917 |
|
|
2024
Q4 | $3.42M | Buy |
205,536
+172,715
| +526% | +$2.3M | ﹤0.01% | 4201 |
|
|
2024
Q3 | $422K | Buy |
32,821
+1,248
| +4% | +$18K | ﹤0.01% | 5349 |
|
|
2024
Q2 | $353K | Sell |
31,573
-31,275
| -50% | -$364K | ﹤0.01% | 5266 |
|
|
2024
Q1 | $779K | Sell |
62,848
-1,219
| -2% | -$20.3K | ﹤0.01% | 4811 |
|
|
2023
Q4 | $1.7M | Sell |
64,067
-5,113
| -7% | -$149K | ﹤0.01% | 3986 |
|
|
2023
Q3 | $3.16M | Buy |
69,180
+924
| +1% | +$42.8K | ﹤0.01% | 3011 |
|
|
2023
Q2 | $2.82M | Buy |
68,256
+14,873
| +28% | +$488K | ﹤0.01% | 3188 |
|
|
2023
Q1 | $1.66M | Buy |
53,383
+21,544
| +68% | +$694K | ﹤0.01% | 3628 |
|
|
2022
Q4 | $640K | Buy |
31,839
+4,420
| +16% | +$94.5K | ﹤0.01% | 4475 |
|
|
2022
Q3 | $387K | Buy |
27,419
+7,919
| +41% | +$107K | ﹤0.01% | 4559 |
|
|
2022
Q2 | $146K | Buy |
19,500
+14,251
| +271% | +$118K | ﹤0.01% | 5139 |
|
|
2022
Q1 | $54K | Sell |
5,249
-14,138
| -73% | -$181K | ﹤0.01% | 6411 |
|
|
2021
Q4 | $469K | Buy |
+19,387
| New | +$379K | ﹤0.01% | 5029 |
|
|
2021
Q3 | – | Sell |
-2,858
| Closed | -$8K | – | 9467 |
|
|
2021
Q2 | $8K | Buy |
+2,858
| New | +$6.84K | ﹤0.01% | 8220 |
|
|
2020
Q4 | – | Sell |
-7,842
| Closed | -$11K | – | 8347 |
|
|
2020
Q3 | $11K | Buy |
7,842
+3,246
| +71% | +$6.02K | ﹤0.01% | 6745 |
|
|
2020
Q2 | $9K | Buy |
+4,596
| New | +$7.92K | ﹤0.01% | 7061 |
|
|
2019
Q4 | – | Sell |
-4,757
| Closed | -$9K | – | 8076 |
|
|
2019
Q3 | $9K | Sell |
4,757
-1,080
| -19% | -$1.55K | ﹤0.01% | 7206 |
|
|
2019
Q2 | $10K | Buy |
5,837
+1,129
| +24% | +$1.86K | ﹤0.01% | 7052 |
|
|
2019
Q1 | $7K | Buy |
+4,708
| New | +$6.36K | ﹤0.01% | 6990 |
|
|
2018
Q4 | – | Sell |
-1,838
| Closed | -$4K | – | 7994 |
|
|
2018
Q3 | $4K | Sell |
1,838
-1,551
| -46% | -$3.84K | ﹤0.01% | 7551 |
|
|
2018
Q2 | $8K | Buy |
+3,389
| New | +$8.36K | ﹤0.01% | 7243 |
|
|
2017
Q2 | – | Sell |
-960
| Closed | -$5K | – | 7623 |
|
|
2017
Q1 | $5K | Sell |
960
-1,016
| -51% | -$3.82K | ﹤0.01% | 6970 |
|
|
2016
Q4 | $5K | Buy |
+1,976
| New | +$5.7K | ﹤0.01% | 7228 |
|
|
2015
Q4 | – | Sell |
-1,617
| Closed | -$4K | – | 8303 |
|
|
2015
Q3 | $4K | Buy |
+1,617
| New | +$3.56K | ﹤0.01% | 7795 |
|
|
2015
Q1 | – | Sell |
-632
| Closed | -$2K | – | 8730 |
|
|
2014
Q4 | $2K | Buy |
+632
| New | +$1.55K | ﹤0.01% | 9376 |
|
Other funds holding AEHR
AIC
VCM
VPM
NCGI
UBS Group's AEHR Position: Q1 2026 in Review
UBS Group increased its Aehr Test Systems (AEHR) stake by 1.5% in Q1 2026, buying an estimated $116K and bringing the position to 246,763 shares worth $9.15M. The position accounts for ﹤0.01% of the portfolio, ranked #3461.
UBS Group first reported a position in AEHR in Q4 2014 and has held it in 30 quarters since. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.
- UBS Group held 246,763 shares of Aehr Test Systems worth $9.15M as of Q1 2026.
- UBS Group bought 3,634 Aehr Test Systems shares in Q1 2026, an estimated $116K.
- Aehr Test Systems made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3461 holding.
- UBS Group first reported a position in Aehr Test Systems in Q4 2014 and has held it in 30 quarters since.
- 191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.